Cargando…

Bioinformatics analysis identifies DYNC1I1 as prognosis marker in male patients with liver hepatocellular carcinoma

BACKGROUND: Liver hepatocellular carcinoma (LIHC) is one of the most common malignant tumors. However, the etiology and exact molecular mechanism of LIHC are still not fully understood, which makes it urgent for us to further study the molecular events behind. METHODS: In this study, differences in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jian, Zhu, Yue, Ma, Songlin, Li, Yi, Liu, Kun, Xu, Sihuan, Li, Xin, Li, Li, Hu, Junfang, Liu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535175/ https://www.ncbi.nlm.nih.gov/pubmed/34679093 http://dx.doi.org/10.1371/journal.pone.0258797

Ejemplares similares

Whole-exome sequencing identifies a novel de novo mutation in DYNC1H1 in epileptic encephalopathies
por: Lin, Zhongdong, et al.
Publicado: (2017)

DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression
por: Gong, Li-Bao, et al.
Publicado: (2019)

Corrigendum: DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression
por: Gong, Li-Bao, et al.
Publicado: (2022)

TNPO2 operates downstream of DYNC1I1 and promotes gastric cancer cell proliferation and inhibits apoptosis
por: Gong, Libao, et al.
Publicado: (2019)

Expanding the Phenotypic and Genetic Spectrum of Neuromuscular Diseases Caused by DYNC1H1 Mutations
por: Li, Jia-Tong, et al.
Publicado: (2022)

Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation
por: Zhou, Jian, et al.
Publicado: (2021)

De Novo Variants in the DYNC1H1 Gene Associated With Infantile Spasms
por: Yang, Haipo, et al.
Publicado: (2021)

Identification of a de novo DYNC1H1 mutation via WES according to published guidelines
por: Ding, Dongxue, et al.
Publicado: (2016)

DYNC1H1 variant associated with epilepsy: Expanding the phenotypic spectrum
por: Chung, Chi-Ting, et al.
Publicado: (2022)

THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation
por: Ding, Yuxi, et al.
Publicado: (2022)

Dync1li1 is required for the survival of mammalian cochlear hair cells by regulating the transportation of autophagosomes
por: Zhang, Yuan, et al.
Publicado: (2022)

Cellular model of neuronal atrophy induced by DYNC1I1 deficiency reveals protective roles of RAS-RAF-MEK signaling
por: Liu, Zhi-Dong, et al.
Publicado: (2016)

Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments
por: Hu, Xueting, et al.
Publicado: (2022)

Whole‐exome sequencing identified two novel mutations of DYNC2LI1 in fetal skeletal ciliopathy
por: Zhang, Xinyue, et al.
Publicado: (2020)

Congenital Cataracts and Gut Dysmotility in a DYNC1H1 Dyneinopathy Patient
por: Gelineau-Morel, Rose, et al.
Publicado: (2016)

De novo DYNC1H1 mutation causes infantile developmental and epileptic encephalopathy with brain malformations
por: Su, Tangfeng, et al.
Publicado: (2022)

Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis
por: Liu, Hua, et al.
Publicado: (2021)

DYNC2H1 hypomorphic or retina-predominant variants cause nonsyndromic retinal degeneration
por: Vig, Anjali, et al.
Publicado: (2020)

DYNC2LI1 mutations broaden the clinical spectrum of dynein-2 defects
por: Kessler, Kristin, et al.
Publicado: (2015)

Association of DYNC1H1 gene SNP/CNV with disease susceptibility, GCs efficacy, HRQOL, anxiety, and depression in Chinese SLE patients
por: Huang, Shunwei, et al.
Publicado: (2021)

Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
por: Liu, Hua, et al.
Publicado: (2022)

Effect of conditional deletion of cytoplasmic dynein heavy chain DYNC1H1 on postnatal photoreceptors
por: Dahl, Tiffanie M., et al.
Publicado: (2021)

Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker
por: Bai, Jin, et al.
Publicado: (2020)

Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma
por: Liangyu, Zhu, et al.
Publicado: (2023)

Bioinformatics screening the novel and promising targets of curcumin in hepatocellular carcinoma chemotherapy and prognosis
por: Yang, Tingting, et al.
Publicado: (2022)

A novel DYNC1H1 mutation causing spinal muscular atrophy with lower extremity predominance
por: Niu, Qi, et al.
Publicado: (2015)

Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis
por: Li, Ying, et al.
Publicado: (2021)

Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma
por: Zhang, Yingai, et al.
Publicado: (2019)

Bioinformatic identification of differentially expressed genes associated with hepatocellular carcinoma prognosis
por: Huang, Xu, et al.
Publicado: (2022)

Bioinformatics Analysis Identifies ASCL1 as the Key Transcription Factor in Hepatocellular Carcinoma Progression
por: Zhang, Hong-yan, et al.
Publicado: (2023)

Mutations in DYNC2LI1 disrupt cilia function and cause short rib polydactyly syndrome
por: Taylor, S. Paige, et al.
Publicado: (2015)

Bioinformatics Analysis based on Multiple Databases Identifies Hub Genes Associated with Hepatocellular Carcinoma
por: Zeng, Lu, et al.
Publicado: (2019)

A novel de novo mutation in DYNC1H1 gene underlying malformation of cortical development and cataract
por: Hertecant, Jozef, et al.
Publicado: (2016)

The clinical-phenotype continuum in DYNC1H1-related disorders—genomic profiling and proposal for a novel classification
por: Becker, Lena-Luise, et al.
Publicado: (2020)

Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic study
por: Liu, JinHui, et al.
Publicado: (2020)

Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma
por: Chen, Qing-Lian, et al.
Publicado: (2021)

Genetic variations in the DYNC2H1 gene causing SRTD3 (short-rib thoracic dysplasia 3 with or without polydactyly)
por: Chen, Wenqi, et al.
Publicado: (2023)

The four-microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients
por: Zhang, Siwei, et al.
Publicado: (2019)

Deletions of exons with regulatory activity at the DYNC1I1 locus are associated with split-hand/split-foot malformation: array CGH screening of 134 unrelated families
por: Tayebi, Naeimeh, et al.
Publicado: (2014)

Protein Phosphatase Magnesium-Dependent 1δ (PPM1D) mRNA Expression Is a Prognosis Marker for Hepatocellular Carcinoma
por: Li, Guang-Bing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c1osdbpef6i2k8ljon0qgdomm6